Compare Johnson & Johnson (JNJ) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs United States Oil ETF — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while United States Oil ETF trades at $148.2 (market cap $1.90B). The key difference: Johnson & Johnson is far larger — about 325.3× United States Oil ETF's market cap, and Johnson & Johnson pays a 2.09% dividend while United States Oil ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and United States Oil ETF for 21 Days on average.
| JNJ | USO | |
|---|---|---|
Market Cap | $618.09B | $1.90B |
Volume | 6,050,983 | 5,932,922 |
Sector | Health | — |
52-Week High | $278.43 | $161.86 |
52-Week Low | $186.00 | $66.17 |
Typical Hold Time | 129 Days | 21 Days |
Enterprise Value | $646.37B | — |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 28.45% net profit margin and consistent revenue growth to $94.19B in 2025. Analyst consensus remains positive with a $286.53 price target, though technical indicators show resistance at $258 and support at $253. Recent news highlights pipeline strength including Icotyde's $4.5B peak sales potential (Bank of America, 2026-09-29).
JNJ presents a compelling long-term investment with diversified healthcare exposure and dividend stability, though near-term technical weakness and patent cliff concerns warrant caution. The 52.5% buy rating from analysts reflects confidence in innovation pipeline, while debt-to-asset ratio increase to 24.06% merits monitoring. Upside potential exists if Q3 earnings beat expectations on October 13.
USO shows strong momentum with a 2.98% gain to $148.20, supported by bullish technical signals including positive moving averages and key resistance at $150. The oil sector faces mixed fundamentals with OPEC+ maintaining steady output while geopolitical tensions in the Middle East create supply uncertainty. Recent news highlights attacks on oil infrastructure and G-7 reserve releases impacting global oil markets.
The stock presents upside potential toward $152-154 resistance levels, though risks include oil price volatility from geopolitical events and potential supply disruptions. Investor sentiment remains cautiously optimistic given the technical strength, but fundamental clarity on earnings and margins is needed for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
